Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patricia I. Mighiu"'
Autor:
Maureen J. Charron, Madhu Chari, Nikita R Christian, Jessica T.Y. Yue, Beatrice M. Filippi, Clair S. Yang, Carol K.L. Lam, Tony K.T. Lam, Patricia I. Mighiu, Mona A. Abraham
Publikováno v:
Nature Medicine. 19:766-772
Glucagon activates hepatic protein kinase A (PKA) to increase glucose production, but the gluco-stimulatory effect is transient even in the presence of continuous intravenous glucagon infusion. Continuous intravenous infusion of insulin, however, inh
Publikováno v:
Circulation Research. 110:1345-1354
Rationale: Dysregulation of hepatic triglyceride (TG)-rich very low-density lipoproteins (VLDL-TG) in obesity and type 2 diabetes contributes to the dyslipidemia that leads to cardiovascular morbidity. The central nervous system (CNS), particularly t
Publikováno v:
Diabetes. 61:1350-1352
The upregulation of plasma inflammatory biomarkers in individuals with metabolic syndrome implies that activation of the innate immune response contributes to the pathogenesis of type 2 diabetes (1). Today, a large array of studies has demonstrated t
Publikováno v:
Diabetes
Last year marked the ninetieth anniversary of the discovery of insulin by Nobel Laureates Frederick Banting and John Macleod, as well as Charles Best and James Bertram Collip. The initial success of insulin’s ability to lower glucose levels in type
Autor:
Beatrice M. Filippi, Mona A. Abraham, Mary P. LaPierre, Tony K.T. Lam, Patricia I. Mighiu, Jessica T.Y. Yue, Peter E. Light
Publikováno v:
Nature communications. 6
The brain emerges as a regulator of hepatic triglyceride-rich very-low-density lipoproteins (VLDL-TG). The neurocircuitry involved as well as the ability of fatty acids to trigger a neuronal network to regulate VLDL-TG remain unknown. Here we demonst
Autor:
Katie Lee, Penny Y.T. Wang, Teresa Y.Y. Lai, Clair S. Yang, Madhu Chari, Tony K.T. Lam, Patricia I. Mighiu, Andrea Kokorovic, Carol K.L. Lam, Grace W.C. Cheung
Publikováno v:
Diabetes
OBJECTIVE Circulating glucose inhibits glucose production in normal rodents and humans, but this glucose effectiveness is disrupted in diabetes due partly to sustained hyperglycemia. We hypothesize that hyperglycemia in diabetes impairs hypothalamic